Skip to content

Concentration screening test for intervention study on analgesic effect of diluted nitrous oxide in rehabilitation training of patients with scar contracture after burn surgery

Concentration screening test for intervention study on analgesic effect of diluted nitrous oxide in rehabilitation training of patients with scar contracture after burn surgery

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500104584
Enrollment
Unknown
Registered
2025-06-19
Start date
2025-07-01
Completion date
Unknown
Last updated
2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

rehabilitation training

Interventions

50% concentration nitrous oxide group:Inhalation of 50% concentration of diluted nitrous oxide
55% concentration nitrous oxide group:Inhalation of 55% concentration of diluted nitrous oxide
60% concentration nitrous oxide group:Inhalation of 60% concentration of diluted nitrous oxide
65% concentration nitrous oxide group:Inhalation of 65% concentration of diluted nitrous oxide

Sponsors

The No.960 hospital of PLA
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 55 Years

Inclusion criteria

Inclusion criteria: 1. Age 18-55 years old; 2. Patients with pain score VAS greater than 4; 3. The patient's trauma does not affect the use of multifunctional ECG monitor or pulse oximetry monitor; 4. Voluntarily participate and sign the informed consent form; 5. The patient is conscious and able to correctly understand and use the visual analogue pain scoring tool to express the degree of pain.

Exclusion criteria

Exclusion criteria: 1. Intestinal obstruction, air embolism, pneumothorax, pneumoencephalogram, epilepsy, obstructive respiratory diseases and acute upper respiratory tract infection, pregnant women, combined with other severe compound injuries; 2. Patients with severe drug dependence and mental abnormalities; 3. Patients with drug-induced or disease-induced pulmonary fibrosis; 4. Diseases of the ear, nose and throat and other organs, such as sinusitis, middle ear diseases, tympanic membrane transplantation, and a history of abuse of analgesic drugs in the past.

Design outcomes

Primary

MeasureTime frame
Pain score;Anxiety score;

Secondary

MeasureTime frame
Physiological parameters;Satisfaction;Side effects;

Countries

China

Contacts

Public ContactLu Tang

The 960th Hospital of PLA

tanglu_office@163.com+86 150 6400 3655

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026